Divi's Laboratories Ltd (NSE:DIVISLAB) Share Price

Company Profile

Business description
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
Contact
Cyber Hills
Divi Towers, 1-72/23(P)/DIVIS/303
Gachibowli
HyderabadTG500032
IND
T: +91 4066966300
https://www.divislabs.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
9,109

Recommended

We were wrong when we thought last quarter would be hard to top.

Dan Romanoff, CPA | 31 July 2025

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 30 July 2025

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.

Shaun Ler | 30 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,917.10	81.90	-0.91%
CAC 40	7,542.51	229.46	-2.95%
DAX 40	23,440.64	624.83	-2.60%
Dow JONES (US)	43,452.60	678.38	-1.54%
FTSE 100	9,040.42	92.39	-1.01%
HKSE	24,507.81	265.52	-1.07%
NASDAQ	20,669.12	453.32	-2.15%
Nikkei 225	40,799.60	270.22	-0.66%
NZX 50 Index	12,729.40	94.34	-0.74%
S&P 500	6,232.80	106.59	-1.68%
S&P/ASX 200	8,662.00	80.80	-0.92%
SSE Composite Index	3,559.95	13.26	-0.37%